Autophagy as a molecular target for cancer treatment
No Thumbnail Available
Date
2019
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier
Open Access Color
OpenAIRE Downloads
OpenAIRE Views
Abstract
Autophagy is an evolutionarily conserved catabolic mechanism, by which eukaryotic cells recycle or degrades internal constituents through membrane-trafficking pathway. Thus, autophagy provides the cells with a sustainable source of biomolecules and energy for the maintenance of homeostasis under stressful conditions such as tumor microenvironment. Recent findings revealed a close relationship between autophagy and malignant transformation. However, due to the complex dual role of autophagy in tumor survival or cell death, efforts to develop efficient treatment strategies targeting the autophagy/cancer relation have largely been unsuccessful. Here we review the two-faced role of autophagy in cancer as a tumor suppressor or as a pro-oncogenic mechanism. In this sense, we also review the shared regulatory pathways that play a role in autophagy and malignant transformation. Finally, anti-cancer therapeutic agents used as either inhibitors or inducers of autophagy have been discussed.
Description
kig, cenk/0000-0002-6318-5001; Kocaturk, Nur/0000-0002-4452-9913; Akkoc, Yunus/0000-0001-5379-6151; bayraktar ekmekcigil, oznur/0000-0002-4824-9943; Devrim, Gozuacik/0000-0001-7739-2346; Kutlu, Ozlem/0000-0002-3769-2536
Keywords
Autophagy, Cancer, Therapeutic agents
Turkish CoHE Thesis Center URL
Fields of Science
Citation
251
WoS Q
Q2
Scopus Q
Q1
Source
Annual Meeting of the European-Federation-of-Pharmaceutical-Sciences (EUFEPS) -- MAY 24-26, 2018 -- Athens, GREECE
Volume
134
Issue
Start Page
116
End Page
137